Michael Egholm - 20 Nov 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: President & CEO, Director
Issuer ticker: LAB
Reported as of: 20 Nov 2024
Net transaction value: -$43,480
SEC form: 4
Accepted by SEC: 21 Nov 2024, 20:55:41 UTC
Prior SEC filing: 05 Sep 2024
Next SEC filing: 24 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Egholm by Agnieszka Gallagher, Attorney-in-Fact

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 21 Nov 2024.

Key facts

This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Nov 2024, 20:55.

Change

Previous filing in this sequence was filed on 05 Sep 2024.
Current net transaction value: -$43,480.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB transaction

Common Stock

Tax liability

Transaction value: $43,480
Shares: -28,795
Change %: -1.9%
Price: $1.51
Shares after: 1,473,704
Date: 20 Nov 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024.